Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jiejin Zhu, Wanshu Li, Changcheng Shi & Qingyu Li. (2022) A pharmacoeconomic evaluation of the pharmacotherapeutic options for painful diabetic neuropathy. Expert Opinion on Pharmacotherapy 23:5, pages 551-559.
Read now
Read now
Manabu Akazawa, Ataru Igarashi, Nozomi Ebata, Tatsunori Murata, Shigeki Zeniya, Yuri Haga, Kazutaka Nozawa, Koichi Fujii & Toshihiko Taguchi. (2019) A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan. Journal of Pain Research 12, pages 2785-2797.
Read now
Read now
Simone Critchlow, Matthew Hirst, Ron Akehurst, Ceri Phillips, Zoe Philips, Will Sullivan & Will C.N. Dunlop. (2017) A systematic review of cost-effectiveness modeling of pharmaceutical therapies in neuropathic pain: variation in practice, key challenges, and recommendations for the future. Journal of Medical Economics 20:2, pages 129-139.
Read now
Read now
Ataru Igarashi, Manabu Akazawa, Tatsunori Murata, Toshihiko Taguchi, Alesia Sadosky, Nozomi Ebata, Richard Willke, Koichi Fujii, Jim Doherty & Makoto Kobayashi. (2015) Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan. ClinicoEconomics and Outcomes Research 7, pages 505-520.
Read now
Read now
Articles from other publishers (13)
Tak Kyu Oh & In-Ae Song. (2023) Association between socioeconomic status and treatment in patients with low back or neck pain: a population-based cross-sectional study in South Korea. Regional Anesthesia & Pain Medicine, pages rapm-2022-104246.
Crossref
Crossref
Deborah Dowell, Kathleen R. Ragan, Christopher M. Jones, Grant T. Baldwin & Roger Chou. (2022)
CDC Clinical Practice Guideline for Prescribing Opioids for Pain
—
United States, 2022
. MMWR. Recommendations and Reports 71:3, pages 1-95.
Crossref
Crossref
Stephanie Mathieson, Chung-Wei Christine Lin, Martin Underwood & Sam Eldabe. (2020) Pregabalin and gabapentin for pain. BMJ, pages m1315.
Crossref
Crossref
Natalia Ruiz-Negrón, Jyothi Menon, Jordan B. King, Junjie Ma & Brandon K. Bellows. (2019) Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review. PharmacoEconomics 37:5, pages 669-688.
Crossref
Crossref
Griffin A. TyreeReith SarkarBrandon K. BellowsRonald J. EllisJoseph Hampton AtkinsonThomas D. MarcotteMark S. WallaceIgor GrantYuyan ShiJames D. MurphyDavid J. Grelotti. (2019) A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain. Cannabis and Cannabinoid Research 4:1, pages 62-72.
Crossref
Crossref
W. Sullivan, M. Hirst, S. Beard, D. Gladwell, F. Fagnani, J. López Bastida, C. Phillips & W. C. N. Dunlop. (2015) Economic evaluation in chronic pain: a systematic review and de novo flexible economic model. The European Journal of Health Economics 17:6, pages 755-770.
Crossref
Crossref
Bruce C. M. Wang, Dongdong Liu, Wesley E. Furnback, Fan Bifa, Peng Dong, Li Xie, Gregory F. Guzauskas & Sali Zhang. (2016) The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China. Pain and Therapy 5:1, pages 81-91.
Crossref
Crossref
Brandon K. Bellows, Richard E. Nelson, Gary M. Oderda & Joanne LaFleur. (2016) Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine. Pain 157:1, pages 203-213.
Crossref
Crossref
Adrian Gheorghe, Grace Moran, Helen Duffy, Tracy Roberts, Thomas Pinkney & Melanie Calvert. (2015) Health Utility Values Associated with Surgical Site Infection: A Systematic Review. Value in Health 18:8, pages 1126-1137.
Crossref
Crossref
Lindsay Parker, Rachel Huelin, Zarmina Khankhel, Radek Wasiak & Joaquin Mould. (2015) A Systematic Review of Pharmacoeconomic Studies for Pregabalin. Pain Practice 15:1, pages 82-94.
Crossref
Crossref
José-Luis de la Calle, José De Andres, María Pérez & Vanessa López. (2014) Add-On Treatment with Pregabalin for Patients with Uncontrolled Neuropathic Pain Who Have Been Referred to Pain Clinics. Clinical Drug Investigation 34:12, pages 833-844.
Crossref
Crossref
Stephanie Mathieson, Christopher G Maher, Andrew J McLachlan, Jane Latimer, Bart W Koes, Mark J Hancock, Ian Harris, Richard O Day, Justin Pik, Stephen Jan, Laurent Billot & Chung-Wei Christine Lin. (2013) PRECISE - pregabalin in addition to usual care for sciatica: study protocol for a randomised controlled trial. Trials 14:1.
Crossref
Crossref
Concepción Pérez, Ana Navarro, María T. Saldaña, Marta Figueras-Balsells, Marta Muñoz-Tudurí & Javier Rejas. (2013) Cost Savings Associated With Early Initiation of Pregabalin in the Management of Peripheral Neuropathic Pain. The Clinical Journal of Pain 29:6, pages 471-477.
Crossref
Crossref